JPLA
ARNA

Joseph P. Lucia & Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Joseph P. Lucia & Associates’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150
Closed -$9K – 599
2021
Q3 		$9K Sell
150
-75
-33% -$4.43K 0.01% 393
2021
Q2 		$15K Hold
225
– – 0.01% 354
2021
Q1 		$16K Hold
225
– – 0.01% 316
2020
Q4 		$17K Buy
+225
New +$16.9K 0.01% 292

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Joseph P. Lucia & Associates's ARNA Position: Q4 2021 in Review

Joseph P. Lucia & Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 150 shares — an estimated $9K sold.

Joseph P. Lucia & Associates first reported a position in ARNA in Q4 2020 and held it in 4 quarters. The position peaked at $17K in Q4 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Joseph P. Lucia & Associates reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 150 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $9K.
  • Joseph P. Lucia & Associates first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 4 quarters.
  • Joseph P. Lucia & Associates's Arena Pharmaceuticals Inc position peaked at $17K in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Joseph P. Lucia & Associates's 13F filing for Q4 2021, filed 4 Feb 2022.